Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC); Meeting, 75158 [2014-29487]
Download as PDF
<![CDATA[
75158
Federal Register / Vol. 79, No. 242 / Wednesday, December 17, 2014 / Notices
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–29488 Filed 12–16–14; 8:45 am]
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2014–29487 Filed 12–16–14; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–2033]
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC); Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date: 11:00 a.m.–1:00 p.m.
(EST), January 13, 2015.
Place: This meeting will be held by
teleconference.
Status: Open to the public, limited only by
the availability of telephone ports. The
public is welcome to participate during the
public comment period, tentatively
scheduled from 12:45 p.m. until 12:50 p.m.
To participate in the teleconference, please
dial (877) 930–8819 and enter code 1579739.
Purpose: The Advisory Committee to the
Director, CDC, shall advise the Secretary,
HHS, and the Director, CDC, on policy and
broad strategies that will enable CDC to fulfill
its mission of protecting health through
health promotion, prevention, and
preparedness. The committee recommends
ways to prioritize CDC’s activities, improve
results, and address health disparities. It also
provides guidance to help CDC work more
effectively with its various private and public
sector constituents to make health protection
a practical reality.
Matters for Discussion: The Advisory
Committee to the Director will receive
updates from the State, Tribal, Local and
Territorial Subcommittee; the External
Laboratory Safety Workgroup, and the Public
Health—Health Care Collaboration
Workgroup; and an update from the CDC
Director on the Ebola response.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Carmen Villar, MSW, Designated Federal
Officer, ACD, CDC, 1600 Clifton Road NE.,
M/S D–14, Atlanta, Georgia 30333;
Telephone (404) 639–7158; Email:
GHickman@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
VerDate Sep<11>2014
19:49 Dec 16, 2014
Jkt 235001
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Survey on the
Occurrence of Foodborne Illness Risk
Factors in Selected Institutional
Foodservice and Retail Food Stores
Facility Types
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
a survey entitled ‘‘Survey on the
Occurrence of Foodborne Illness Risk
Factors in Selected Institutional
Foodservice and Retail Food Stores
Facility Types (2015–2025).’’
DATES: Submit either electronic or
written comments on the collection of
information by February 17, 2015.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
SUMMARY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
SUPPLEMENTARY INFORMATION:
Survey on the Occurrence of Foodborne
Illness Risk Factors in Selected Retail
and Foodservice Facility Types (2015–
2025) (OMB Control Number 0910–
NEW)
I. Background
From 1998–2008, FDA’s National
Retail Food Team conducted a study to
measure trends in the occurrence of
foodborne illness risk factors,
preparation practices, and employee
behaviors most commonly reported to
the Centers for Disease Control and
Prevention as contributing factors to
foodborne illness outbreaks at the retail
level. Specifically, data was collected by
FDA Specialists in retail and
foodservice establishments at 5-year
intervals (1998, 2003, and 2008) in order
to observe and document trends in the
occurrence of the following foodborne
illness risk factors:
• Food from Unsafe Sources,
• Poor Personal Hygiene,
• Inadequate Cooking,
E:\FR\FM\17DEN1.SGM
17DEN1
]]>Agencies
[Federal Register Volume 79, Number 242 (Wednesday, December 17, 2014)]
[Notices]
[Page 75158]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-29487]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC); Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Time and Date: 11:00 a.m.-1:00 p.m. (EST), January 13, 2015.
Place: This meeting will be held by teleconference.
Status: Open to the public, limited only by the availability of
telephone ports. The public is welcome to participate during the
public comment period, tentatively scheduled from 12:45 p.m. until
12:50 p.m.
To participate in the teleconference, please dial (877) 930-8819
and enter code 1579739.
Purpose: The Advisory Committee to the Director, CDC, shall
advise the Secretary, HHS, and the Director, CDC, on policy and
broad strategies that will enable CDC to fulfill its mission of
protecting health through health promotion, prevention, and
preparedness. The committee recommends ways to prioritize CDC's
activities, improve results, and address health disparities. It also
provides guidance to help CDC work more effectively with its various
private and public sector constituents to make health protection a
practical reality.
Matters for Discussion: The Advisory Committee to the Director
will receive updates from the State, Tribal, Local and Territorial
Subcommittee; the External Laboratory Safety Workgroup, and the
Public Health--Health Care Collaboration Workgroup; and an update
from the CDC Director on the Ebola response.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Carmen Villar, MSW,
Designated Federal Officer, ACD, CDC, 1600 Clifton Road NE., M/S D-
14, Atlanta, Georgia 30333; Telephone (404) 639-7158; Email:
GHickman@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2014-29487 Filed 12-16-14; 8:45 am]
BILLING CODE 4163-18-P
